再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

未开盘 03-23 16:08:09

13.650

-0.570

-4.01%

最高14.000	最低13.340	成交量1,091万
今开14.000	昨收14.220	日振幅4.64%
总市值153.97亿	流通市值153.97亿	总股本11.28亿
成交额1.49亿	换手率0.97%	流通股本11.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":13.65,"timestamp":1774253289010,"preClose":14.22,"halted":0,"volume":10905700,"delay":0,"changeRate":-0.040084388185654025,"floatShares":1128000000,"shares":1128000000,"eps":-1.2554404875679572,"marketStatus":"未开盘","change":-0.57,"latestTime":"03-23 16:08:09","open":14,"high":14,"low":13.34,"amount":148889030,"amplitude":0.046414,"askPrice":13.65,"askSize":46900,"bidPrice":13.63,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-1.2554404875679572,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774315800000},"marketStatusCode":0,"adr":0,"listingDate":1601222400000,"exchange":"SEHK","adjPreClose":14.22,"openAndCloseTimeList":[[1774229400000,1774238400000],[1774242000000,1774252800000]],"volumeRatio":1.799356,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688","defaultTab":"news","newsList":[{"id":"2621095723","title":"【券商聚焦】交银国际：CXO行情持续回暖 料板块估值倍数合理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095723","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095723?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:25","pubTimestamp":1774232735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，多重利好因素共振下，2025年以来CXO行情持续回暖。该机构建议重点关注标的细分赛道成长力、核心能力布局、盈利和订单增长能见度、地缘风险敞口及估值上升空间。基于此，该机构首推药明合联，首次覆盖并重点推荐凯莱英和康龙化成。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","LU2399975544.HKD","02367","LU0540923850.HKD","LU1303224171.USD","LU2476274720.SGD","01530","LU0634319403.HKD","LU1115378108.SGD","BK1197","06160","LU0348827113.USD","IE00BPRC5H50.USD","LU1719994722.HKD","IE00B543WZ88.USD","BK1161","LU0348766576.USD","LU0348767384.USD","LU2476274308.USD","LU2488822045.USD","BK1585","BK1588","09926","BK1593","LU1794554557.SGD","BK1583","BK1141","02196","01099","BK1574","LU2778985437.USD","03933","09688","BK1500","BK1191","LU1770034418.SGD","LU0348735423.USD","06821","BK1617","03329","LU2328871848.SGD","LU0417516571.SGD","02228","BK1207","LU0307460666.USD","LU0348784397.USD","LU0417516738.SGD","02268","LU0417516902.SGD","CXO"],"gpt_icon":0},{"id":"2619546907","title":"再鼎医药(09688.HK)拟3月26日(美国东部时间)/3月27日(香港时间)举行董事会会议以审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2619546907","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619546907?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:07","pubTimestamp":1773670021,"startTime":"0","endTime":"0","summary":"格隆汇3月16日丨再鼎医药(09688.HK)公告，董事会将于2026年3月26日(星期四，美国东部时间)/2026年3月27日(星期五，香港时间)审议及批准(其中包括)根据香港联合交易所有限公司证券上市规则编制的公司及其附属公司截至2025年12月31日止年度的年度业绩及其发布。\r\n\r\n　　公司先前已公布其根据美国公认会计准则编制的年度业绩，并于2026年2月26日(星期四，美国东部时间/香港时间)以表格10-K向美国证券交易委员会(\"美国证交会\")提交其截至2025年12月31日止年度的年度报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260316/32072706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1588","09688","LU2488822045.USD","ZLAB","BK4588","BK1574","BK4526","BK4548","BK1161","BK4531","BK4585","BK4139"],"gpt_icon":0},{"id":"2619190413","title":"再鼎医药(09688)：授出购股权、受限制股份单位及业绩股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2619190413","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619190413?lang=zh_cn&edition=full","pubTime":"2026-03-13 21:24","pubTimestamp":1773408240,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，本公司于授出日期根据2024年股权激励计划授出35.34万份购股权、3.24万股受限制股份单位以及17.54万股业绩股份单位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","09688","BK1161","BK4548","ZLAB","BK4585","LU2488822045.USD","BK1588","BK4526","BK4531","BK1574","BK4139"],"gpt_icon":0},{"id":"2619594441","title":"每日卖空追踪 | 再鼎医药 03月12日卖空量成交57.47万股，卖空比例为5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619594441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619594441?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304243,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间03月12日，跌2.85%，卖空量成交57.47万股，较上一交易日增加81.24%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163629a46376ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163629a46376ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2488822045.USD","09688","BK1588","BK1574"],"gpt_icon":0},{"id":"2618183638","title":"每日卖空追踪 | 再鼎医药 03月11日卖空量成交14.71万股，卖空比例为2.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618183638","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618183638?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217842,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间03月11日，涨0.07%，卖空量成交14.71万股，较上一交易日减少79.78%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163627a6b79736&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163627a6b79736&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","LU2488822045.USD","09688","BK1161","BK1574"],"gpt_icon":0},{"id":"2618862761","title":"再鼎医药(09688)授出购股权、受限制股份单位及业绩股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2618862761","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618862761?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:42","pubTimestamp":1773067323,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)公布，公司于授出日期根据2024年股权激励计划授出可认购37.422万股美国存托股份的购股权、12.162万股美国存托股份受限制股份单位以及18.2428万股美国存托股份的业绩股份单位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1588","BK4526","BK1161","BK4548","09688","ZLAB","BK1574","BK4139","BK4588","BK4531","LU2488822045.USD"],"gpt_icon":0},{"id":"2618036246","title":"每日卖空追踪 | 再鼎医药 03月09日卖空量成交30.84万股，卖空比例为3.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618036246","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618036246?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045042,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间03月09日，跌4.2%，卖空量成交30.84万股，较上一交易日减少39.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163619a6b1c9f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163619a6b1c9f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","LU2488822045.USD","09688","BK1588"],"gpt_icon":0},{"id":"2618036906","title":"再鼎医药03月09日遭主力抛售719.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618036906","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618036906?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:15","pubTimestamp":1773044156,"startTime":"0","endTime":"0","summary":"03月09日, 再鼎医药股价跌4.20%，报收14.83元，成交金额1.3亿元，换手率0.79%，振幅2.20%，量比0.85。再鼎医药今日主力资金净流出719.0万元，上一交易日主力净流出96.7万元。该股近5个交易日上涨4.47%，主力资金累计净流入447.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入6974.9万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309162050a45ad8e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309162050a45ad8e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","BK1574","LU2488822045.USD","BK1588"],"gpt_icon":0},{"id":"2617919503","title":"【券商聚焦】交银国际：医药公司业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617919503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617919503?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:08","pubTimestamp":1772759313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，2026年以来，内资通过港股通持有医药股的比例呈现先降后升态势，当前水平与年初持平，外资持仓则有所提升。本周内资继续加仓创新药产业链和器械标的，外资则重点布局创新药企及CXO企业。年报季临近，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","02268","BK1141","BK1574","02228","LU2399975544.HKD","LU0540923850.HKD","LU2476274720.SGD","06160","BK1515","IE00B5MMRT66.SGD","LU0348783233.USD","03329","BK1593","LU0417516571.SGD","LU2488822045.USD","LU0348735423.USD","IE00BPRC5H50.USD","LU1961090484.USD","BK1197","LU1115378108.SGD","SG9999014674.SGD","09688","LU0640798160.USD","LU1719994722.HKD","01099","BK1207","LU0348784397.USD","LU2476274308.USD","LU0588546209.SGD","02367","BK1585","01530","LU0348827113.USD","LU0561508036.HKD","LU1770034418.SGD","SG9999004311.SGD","HK0000165453.HKD","BK1191","LU0348766576.USD","03933","02196","09939","LU2778985437.USD","09926","159938","LU1794554557.SGD","LU2328871848.SGD","LU0348825331.USD","LU1303224171.USD"],"gpt_icon":0},{"id":"2617526522","title":"再鼎医药(09688)授出购股权及受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2617526522","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617526522?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:54","pubTimestamp":1772722453,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，公司于授出日期根据2024年股权激励计划向4名承授人授出可认购合共8万股美国存托股份的购股权并向9名承授人授出涉及合共12.344万股美国存托股份的受限制股份单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410705.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","ZLAB","LU2488822045.USD","BK1588","BK4548","BK4588","BK4139","09688","BK1574","BK4526","BK4531","BK4585"],"gpt_icon":0},{"id":"2617752571","title":"再鼎医药(09688)：Moulder已调任董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2617752571","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617752571?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:39","pubTimestamp":1772721583,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，Leon O. Moulder, Jr.先生已调任公司董事，自本公告之日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09688","BK1161","ZLAB","BK1574","BK4531","LU2488822045.USD","BK1588","BK4526","BK4585","BK4548","BK4588","BK4139"],"gpt_icon":0},{"id":"1110719473","title":"再鼎医药（09688）发布2月股份变动月报，新增发行850万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1110719473","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110719473?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:18","pubTimestamp":1772702289,"startTime":"0","endTime":"0","summary":"2026年3月5日，再鼎医药有限公司发布截至2026年2月28日的月度证券变动公告。公告显示，公司法定股本维持5,000,000,000股普通股不变，对应法定股本总额USD 30,000。本月公司已发行股份由月初的1,119,628,030股增至1,128,128,030股，期间新增8,500,000股，库存股份数目期初期末均为0。公告未披露购回、注销或库藏股活动。公司在2月4日发行8,500,000股新股，并由受托人持有，旨在兑现已归属的权益。截至2月末，公司普通股总数为1,128,128,030股。公告由公司秘书F.Ty Edmondson签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688"],"gpt_icon":0},{"id":"2617510670","title":"每日卖空追踪 | 再鼎医药 03月05日卖空量成交58.25万股，卖空比例为4.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617510670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617510670?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699442,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间03月05日，涨3.93%，卖空量成交58.25万股，较上一交易日减少74.41%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163619a6a5dbf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163619a6a5dbf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1161","BK1588","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2617106555","title":"再鼎医药03月05日主力净流入1376.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2617106555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617106555?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:15","pubTimestamp":1772698519,"startTime":"0","endTime":"0","summary":"03月05日, 再鼎医药股价涨3.93%，报收14.80元，成交金额1.9亿元，换手率1.10%，振幅4.07%，量比1.30。再鼎医药今日主力资金净流入1376.5万元，上一交易日主力净流出320.7万元。该股近5个交易日上涨1.59%，主力资金累计净流入1219.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入7536.7万元，其中净流入天数为13日。该股主力净额占比0.08%，港股市场排名79/2716。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305161602a6a5c454&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305161602a6a5c454&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","BK1588","LU2488822045.USD","BK1574"],"gpt_icon":0},{"id":"1147894824","title":"异动解读 | 再鼎医药盘中大涨5.27%，受美股中概股普涨带动","url":"https://stock-news.laohu8.com/highlight/detail?id=1147894824","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147894824?lang=zh_cn&edition=full","pubTime":"2026-03-05 09:33","pubTimestamp":1772674399,"startTime":"0","endTime":"0","summary":"再鼎医药今日盘中大涨5.27%，引起了市场的广泛关注。消息面上，隔夜美股市场中概股普遍走高，纳斯达克中国金龙指数涨超1%，其中再鼎医药在美股市场（ZLAB.US）涨超4%。全球金融市场出现企稳迹象，美股三大指数集体高开，这提振了市场风险偏好，可能带动了再鼎医药在港股市场的表现。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09688"],"gpt_icon":0},{"id":"2617184025","title":"每日卖空追踪 | 再鼎医药 03月04日卖空量成交77.34万股，卖空比例为7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617184025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617184025?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613041,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间03月04日，涨4.02%，卖空量成交77.34万股，较上一交易日减少42.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163611a44a7104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163611a44a7104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1161","LU2488822045.USD","09688","BK1574"],"gpt_icon":0},{"id":"2616318425","title":"每日卖空追踪 | 再鼎医药 03月02日卖空量成交83.22万股，卖空比例为8.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616318425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616318425?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440244,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间03月02日，跌4.91%，卖空量成交83.22万股，较上一交易日减少18.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163702a4415464&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163702a4415464&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1161","09688","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2616428318","title":"再鼎医药03月02日主力净流出653.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616428318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616428318?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:15","pubTimestamp":1772439326,"startTime":"0","endTime":"0","summary":"03月02日, 再鼎医药股价跌4.91%，报收14.32元，成交金额1.5亿元，换手率0.91%，振幅4.38%，量比1.29。再鼎医药今日主力资金净流出653.1万元，上一交易日主力净流入609.8万元。该股近5个交易日下跌5.88%，主力资金累计净流入1676.3万元；近20日主力资金累计净流入3959.4万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161648a4413850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161648a4413850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","LU2488822045.USD","09688","BK1161","BK1574"],"gpt_icon":0},{"id":"2616538865","title":"【券商聚焦】招银国际：AI将改变创新药物研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538865","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616538865?lang=zh_cn&edition=full","pubTime":"2026-03-02 14:40","pubTimestamp":1772433633,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨5.0%，跑赢MSCI中国指数6.2%。医药行业近期明显回调（MSCI中国医疗指数1月15日至今累计下跌9%），特别是创新药板块回调幅度较大（恒生生物科技指数1月15日至今累计下跌13%）。该机构认为，此轮调整原因包括博弈层面行业短期缺乏催化剂，以及行业轮动导致资金流出医药板块。中国创新药资产出海BD持续超预期，MNC对于中国资产的购买范围从单个管线拓宽至平台合作，进一步体现了中国创新药的竞争力。该机构认为，中国的AI制药技术发展迅猛，将涌现一批优秀的创新企业。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","BK1161","IE00B543WZ88.USD","06978","BK1585","LU0348783233.USD","01099","LU0307460666.USD","02367","LU0348784397.USD","HK0000165453.HKD","02196","LU1961090484.USD","SG9999014674.SGD","LU1969619763.USD","LU1720050803.USD","BK1141","03933","02268","BK1617","09926","159992","BK1100","BK1197","LU2328871848.SGD","LU2488822045.USD","LU2476274720.SGD","SG9999004311.SGD","IE00B5MMRT66.SGD","LU0588546209.SGD","IE00BPRC5H50.USD","LU2399975544.HKD","LU0640798160.USD","06160","LU0348827113.USD","02228","09688","LU1251922891.USD","BK1207","BK1574","LU1303224171.USD","LU0561508036.HKD","01530","LU1794554557.SGD","01789","LU1115378108.SGD","BK1515","BK1583","LU0348735423.USD","LU0348825331.USD"],"gpt_icon":0},{"id":"2614830207","title":"再鼎医药02月27日获主力加仓609.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614830207","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614830207?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:15","pubTimestamp":1772180134,"startTime":"0","endTime":"0","summary":"02月27日, 再鼎医药股价涨4.01%，报收15.06元，成交金额1.7亿元，换手率0.99%，振幅6.63%，量比1.80。再鼎医药今日主力资金净流入609.8万元，连续4日净流入，上一交易日主力净流入635.7万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为69.23%，平均涨幅为3.61%。该股近5个交易日下跌1.37%，主力资金累计净流入2323.2万元；近20日主力资金累计净流入4639.8万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161731a4cefafb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161731a4cefafb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1574","BK1588","BK1161","LU2488822045.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":-0.0651},{"period":"1month","weight":-0.1119},{"period":"3month","weight":0.0015},{"period":"6month","weight":-0.4596},{"period":"1year","weight":-0.5081},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.0769},{"period":"3month","weight":-0.054},{"period":"6month","weight":-0.0806},{"period":"1year","weight":0.0292},{"period":"ytd","weight":-0.0487}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"再鼎医药有限公司是一家主要从事生物制药业务的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、免疫、神经科学和感染性疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物，其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.017355},{"month":2,"riseRate":0.666667,"avgChangeRate":0.068855},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.099495},{"month":4,"riseRate":0.6,"avgChangeRate":0.032813},{"month":5,"riseRate":0.4,"avgChangeRate":-0.024133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013792},{"month":7,"riseRate":0.8,"avgChangeRate":0.065752},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021717},{"month":9,"riseRate":0.4,"avgChangeRate":-0.054178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.051338},{"month":11,"riseRate":0.5,"avgChangeRate":0.047251},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.024481}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}